FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216683313> ?p ?o ?g. }

• W3216683313 abstract "Background: Several bleeding risk assessment models have been developed in atrial fibrillation (AF) patients with oral anticoagulants, but the most appropriate tool for predicting bleeding remains uncertain. Therefore, we aimed to assess the diagnostic accuracy of the Hypertension, Abnormal liver/renal function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs/alcohol concomitantly (HAS-BLED) score compared with other risk scores in anticoagulated patients with AF. Methods: We comprehensively searched the PubMed and Embase databases until July 2021 to identify relevant pieces of literature. The predictive abilities of risk scores were fully assessed by the C-statistic, net reclassification improvement (NRI) and integrated discrimination improvement (IDI) values, calibration data, and decision curve analyses. Results: A total of 39 studies met the inclusion criteria. The C-statistic of the HAS-BLED score for predicting major bleeding was 0.63 (0.61–0.65) in anticoagulated patients regardless of vitamin k antagonists [0.63 (0.61–0.65)] and direct oral anticoagulants [0.63 (0.59–0.67)]. The HAS-BLED had the similar C-statistic to the Hepatic or renal disease, Ethanol abuse, Malignancy, Older, Reduced platelet count or function, Re-bleeding risk, Hypertension (uncontrolled), Anemia, Genetic factors, Excessive fall risk, Stroke (HEMORR 2 HAGES), the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA), the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT), the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), or the Age, Biomarkers, Clinical History (ABC) scores, but significantly higher C-statistic than the Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Stroke/transient ischemic attack history (CHADS 2 ) or the Congestive heart failure/left ventricular ejection fraction ≤ 40%, Hypertension, Age ≥75 years, Diabetes mellitus, Stroke/transient ischemic attack/thromboembolism history, Vascular disease, Age 65–74 years, Sex (female) (CHA 2 DS 2 -VASc) scores. NRI and IDI values suggested that the HAS-BLED score performed better than the CHADS 2 or the CHA 2 DS 2 -VASc scores and had similar or superior predictive ability compared with the HEMORR 2 HAGES, the ATRIA, the ORBIT, or the GARFIELD-AF scores. Calibration and decision curve analyses of the HAS-BLED score compared with other scores required further assessment due to the limited evidence. Conclusion: The HAS-BLED score has moderate predictive abilities for bleeding risks in patients with AF regardless of type of oral anticoagulants. Current evidence support that the HAS-BLED score is at least non-inferior to the HEMORR 2 HAGES, the ATRIA, the ORBIT, the GARFIELD-AF, the CHADS 2 , the CHA 2 DS 2 -VASc, or the ABC scores." @default.
• W3216683313 created "2021-12-06" @default.
• W3216683313 creator A5001633362 @default.
• W3216683313 creator A5005388888 @default.
• W3216683313 creator A5025095731 @default.
• W3216683313 creator A5040333073 @default.
• W3216683313 creator A5078846379 @default.
• W3216683313 date "2021-11-22" @default.
• W3216683313 modified "2023-10-17" @default.
• W3216683313 title "Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis" @default.
• W3216683313 cites W159232318 @default.
• W3216683313 cites W1979731765 @default.
• W3216683313 cites W2017004754 @default.
• W3216683313 cites W2019059960 @default.
• W3216683313 cites W2102996797 @default.
• W3216683313 cites W2114504614 @default.
• W3216683313 cites W2127985968 @default.
• W3216683313 cites W2150893484 @default.
• W3216683313 cites W2163311091 @default.
• W3216683313 cites W2195719407 @default.
• W3216683313 cites W2332141348 @default.
• W3216683313 cites W2336404742 @default.
• W3216683313 cites W2379102440 @default.
• W3216683313 cites W2441152799 @default.
• W3216683313 cites W2591370336 @default.
• W3216683313 cites W2740481260 @default.
• W3216683313 cites W2744036640 @default.
• W3216683313 cites W2756270141 @default.
• W3216683313 cites W2762720447 @default.
• W3216683313 cites W2766187497 @default.
• W3216683313 cites W2776846442 @default.
• W3216683313 cites W2786396286 @default.
• W3216683313 cites W2792545171 @default.
• W3216683313 cites W2890034228 @default.
• W3216683313 cites W2899484044 @default.
• W3216683313 cites W2900136549 @default.
• W3216683313 cites W2904378195 @default.
• W3216683313 cites W2907638671 @default.
• W3216683313 cites W2913005863 @default.
• W3216683313 cites W2959028040 @default.
• W3216683313 cites W2989641937 @default.
• W3216683313 cites W3013883697 @default.
• W3216683313 cites W3016020630 @default.
• W3216683313 cites W3082188176 @default.
• W3216683313 cites W3122402546 @default.
• W3216683313 cites W3131084531 @default.
• W3216683313 cites W3161898407 @default.
• W3216683313 doi "https://doi.org/10.3389/fcvm.2021.757087" @default.
• W3216683313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34881309" @default.
• W3216683313 hasPublicationYear "2021" @default.
• W3216683313 type Work @default.
• W3216683313 sameAs 3216683313 @default.
• W3216683313 citedByCount "18" @default.
• W3216683313 countsByYear W32166833132022 @default.
• W3216683313 countsByYear W32166833132023 @default.
• W3216683313 crossrefType "journal-article" @default.
• W3216683313 hasAuthorship W3216683313A5001633362 @default.
• W3216683313 hasAuthorship W3216683313A5005388888 @default.
• W3216683313 hasAuthorship W3216683313A5025095731 @default.
• W3216683313 hasAuthorship W3216683313A5040333073 @default.
• W3216683313 hasAuthorship W3216683313A5078846379 @default.
• W3216683313 hasBestOaLocation W32166833131 @default.
• W3216683313 hasConcept C11783203 @default.
• W3216683313 hasConcept C126322002 @default.
• W3216683313 hasConcept C127413603 @default.
• W3216683313 hasConcept C164705383 @default.
• W3216683313 hasConcept C2776301958 @default.
• W3216683313 hasConcept C2778661090 @default.
• W3216683313 hasConcept C2779134260 @default.
• W3216683313 hasConcept C2779161974 @default.
• W3216683313 hasConcept C2780638905 @default.
• W3216683313 hasConcept C2780645631 @default.
• W3216683313 hasConcept C71924100 @default.
• W3216683313 hasConcept C78519656 @default.
• W3216683313 hasConceptScore W3216683313C11783203 @default.
• W3216683313 hasConceptScore W3216683313C126322002 @default.
• W3216683313 hasConceptScore W3216683313C127413603 @default.
• W3216683313 hasConceptScore W3216683313C164705383 @default.
• W3216683313 hasConceptScore W3216683313C2776301958 @default.
• W3216683313 hasConceptScore W3216683313C2778661090 @default.
• W3216683313 hasConceptScore W3216683313C2779134260 @default.
• W3216683313 hasConceptScore W3216683313C2779161974 @default.
• W3216683313 hasConceptScore W3216683313C2780638905 @default.
• W3216683313 hasConceptScore W3216683313C2780645631 @default.
• W3216683313 hasConceptScore W3216683313C71924100 @default.
• W3216683313 hasConceptScore W3216683313C78519656 @default.
• W3216683313 hasLocation W32166833131 @default.
• W3216683313 hasLocation W32166833132 @default.
• W3216683313 hasLocation W32166833133 @default.
• W3216683313 hasLocation W32166833134 @default.
• W3216683313 hasOpenAccess W3216683313 @default.
• W3216683313 hasPrimaryLocation W32166833131 @default.
• W3216683313 hasRelatedWork W1993190469 @default.
• W3216683313 hasRelatedWork W1993758186 @default.
• W3216683313 hasRelatedWork W2049310472 @default.
• W3216683313 hasRelatedWork W2321904733 @default.
• W3216683313 hasRelatedWork W2597099584 @default.
• W3216683313 hasRelatedWork W2789710191 @default.
• W3216683313 hasRelatedWork W2793392713 @default.
• W3216683313 hasRelatedWork W2896204226 @default.

• next